This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Recordati Industria Chimica E Farmaceutica S.p.a.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Alberto Mattei: Innovator in Pharmaceutical Formulations
Introduction
Alberto Mattei is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for parenteral administration. His work focuses on enhancing the efficacy and stability of pharmaceutical products.
Latest Patents
Alberto Mattei holds a patent for a pharmaceutical parenteral formulation containing carglumic acid. This innovative formulation is designed for parenteral administration and includes a buffering agent with a pK from 5.5 to 9.0 at 25°C. Specifically, the buffering agent may have a pK from 7.5 to 8.5, with a preferred pK of about 8.07, such as trometamol. Additionally, the formulation may contain bulking agents like mannitol. The invention also encompasses a method for manufacturing a lyophilized sterile formulation through freeze-drying a water solution containing carglumic acid and the buffering agent.
Career Highlights
Alberto Mattei is associated with Recordati Industria Chimica e Farmaceutica S.p.A., where he has been instrumental in advancing pharmaceutical formulations. His expertise in the field has led to the development of innovative solutions that address critical healthcare needs.
Collaborations
Alberto has collaborated with notable colleagues, including Diego Provvedini and Pierluigi Farina. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Alberto Mattei's contributions to pharmaceutical formulations demonstrate his commitment to improving healthcare through innovation. His patent for carglumic acid formulation highlights his role as a key inventor in the industry.